RE:RE:Why would anyone 'want' to attend the AVCN conferenceJAZZ does not have licensing rights to acid form of cannabinoids making them so far a "one hit wonder" or a "one pony show". NO comparison at all to LABS and their global pharma partner, both controlling a large pipeline of over 20 candidates.
Sit tight and wait for Pfizer....and DEA first.